Dr. Christopher M. Russell, MD

Dr. Russell practices at AdventHealth Surgery Center Mills Park in Orlando, Florida.

Dr. Russell's NPI, 1578942918, was assigned on May 19, 2015. Dr. Russell graduated from USF Health Morsani College of Medicine in 2015. Dr. Russell holds Florida license ME141118.

Dr. Russell's primary practice is AdventHealth Surgery Center Mills Park, at 1812 N Mills Ave Ste 210, Orlando, FL 32803. The practice phone is (407) 420-0100.

Dr. Russell's primary practice is AdventHealth Surgery Center Mills Park in Orlando, Florida. Dr. Russell is also affiliated with AdventHealth Orlando. The medical group on file is AdventHealth Medical Group. Dmand AI also links Dr. Russell to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Russell practices, 8 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Russell's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Russell is board certified in urology by the American Board of Urology. Dmand AI has Dr. Russell's licenses on file in 2 states: Florida and Michigan.

Dmand AI lists bladder disease, bladder removal, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery and kidney stone disease among the conditions Dr. Russell treats.

CMS data shows 1,322 Medicare services from Dr. Russell across 16 procedure codes in 2024, for 361 Medicare patients. Medicare paid $102,686 for them.

CMS counts 361 Medicare patients who saw Dr. Russell in 2024. The largest group is 65 to 74, with 171 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Russell's median patient age at 66, with 24% women.

In 2024, Dr. Russell wrote 1,185 Medicare Part D claims for 376 patients. 97% of them were for generic drugs. CMS names the drug for 1,059 of them, across 16 drugs with 11 or more claims each, at $26,269 in total drug cost. In 2023, CMS named 939 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Russell for performance year 2024, reported as part of a group. Dr. Russell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Russell as offering telehealth. CMS counts 14 procedures of prostate resection by Dr. Russell, more than 69% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 11 papers to Dr. Russell, published from 2014 to 2021. 2015 was the busiest year, with 2. The most frequent topics are Carcinoma, Renal Cell, Kidney Neoplasms and Lymph Node Excision. Dr. Russell has published most often in Can J Urol. Dr. Russell's most frequent co-authors are Wade J. Sexton, MD, Philippe E. Spiess, MD and Gautum Agarwal, MD.

CMS Open Payments shows 126 general payments to Dr. Russell from 12 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 43% of the total. Intuitive Surgical, Inc. paid the most, $82,640.

Dmand AI lists 1 award for Dr. Russell.

Dr. Russell graduated from USF Health Morsani College of Medicine in 2015.

Dr. Russell is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.